As of 2025-05-25, the Fair Value of Aclaris Therapeutics Inc (ACRS) is -6.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.26 USD, the upside of Aclaris Therapeutics Inc is -583.99%.
With the market price of 1.26 USD and our fair value calculation, Aclaris Therapeutics Inc (ACRS) is not a good investment. Investing in Aclaris stocks now will result in a potential loss of 583.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -51.02 | -90.87 | -86.91 | -88.48 | -132.06 | -89.87 |
| YoY growth | 68.38% | -78.11% | 4.36% | -1.81% | -49.26% | -11.29% |
| Market Cap (mil) | 136.43 |
| P/E | |
| Forward P/E |
| EPS | -1.22 |
| Avg earnings growth rate | -11.29% |
| TTM earnings | -132.06 |